Welcome to our Media centre. Here you will find a full archive of our news releases and statements, links to
facts and statistics about the pharmaceutical industry and other useful information for the media.
News releases and statements |
Executive biographies | ABPI on social media
The ABPI offices are officially closed from 24 December to 4 January and will fully reopen on 5 January. The ABPI will operate a skeleton staff on 24 December and 2 January.
During the office closure, the ABPI’s Press Office will remain operational for all media enquiries.
Please see the Media enquiries contact details below for further information.
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.
ABPI Press OfficeTelephone: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811Email: